Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Chaga mushroom (Inonotus obliquus) has a long history of use in traditional medicine, particularly in Russia and parts of Asia, for general immune support and as a remedy against various ailments, including viral infections like influenza. Modern research has begun to investigate its antiviral and immunomodulatory properties. Several in vitro studies have demonstrated that extracts of chaga can inhibit the replication of influenza viruses, such as H1N1, potentially by interfering with viral entry or replication and by modulating host immune responses. The mushroom contains bioactive compounds like polysaccharides, polyphenols, and triterpenoids, which are believed to contribute to these effects. However, evidence from human clinical trials is limited. Most of the available data are from laboratory or animal studies, and there is a lack of robust, large-scale clinical evidence to confirm chaga’s effectiveness specifically for the prevention or treatment of influenza in humans. While these preliminary findings are promising and justify further research, they do not yet provide a strong scientific basis for its use against influenza. Therefore, while chaga mushroom is traditionally used for immune support, its specific application for influenza is supported by early scientific research but lacks conclusive clinical validation.

More about chaga mushroom
More about Influenza

Other ingredients used for Influenza

Other health conditions supported by chaga mushroom

Products containing chaga mushroom